GSKH · GSK plc ADRhedged
United States · RS rating 38 · As of 2026-10-14
| Price | 68.35 USD |
|---|---|
| 1-day change | +3.9% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 52 / 40 / 63 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 30 / 20 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +19.4% |
| Market cap (USD) | – |